{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:01:27Z","timestamp":1791615687583,"version":"4.3.4"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.23923","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T15:02:18Z","timestamp":1631804538000},"page":"e2123923","source":"Crossref","is-referenced-by-count":74,"title":["Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease"],"prefix":"10.1001","volume":"4","author":[{"given":"Zobair M.","family":"Younossi","sequence":"first","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"},{"name":"Department of Medicine, Inova Health System, Falls Church, Virginia"},{"name":"Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Felix","sequence":"additional","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jeffers","sequence":"additional","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Younossi","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research in Liver Diseases, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema","family":"Nader","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research in Liver Diseases, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong","family":"Pham","sequence":"additional","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Afendy","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research in Liver Diseases, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cable","sequence":"additional","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Racila","sequence":"additional","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"},{"name":"Department of Medicine, Inova Health System, Falls Church, Virginia"},{"name":"Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Younoszai","sequence":"additional","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Lam","sequence":"additional","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Golabi","sequence":"additional","affiliation":[{"name":"Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Henry","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research in Liver Diseases, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stepanova","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research in Liver Diseases, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"1","key":"zoi210697r1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.v64.1","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"zoi210697r2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"zoi210697r3","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis.","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"zoi210697r4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.","volume":"63","author":"European Association for Study of Liver","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"zoi210697r5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease.","volume":"9","author":"European Association for the Study of the Liver (EASL)","year":"2016","journal-title":"Obes Facts"},{"issue":"1","key":"zoi210697r6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"zoi210697r7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/hep.v70.4","article-title":"Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD.","volume":"70","author":"Rinella","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"zoi210697r8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy.","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"zoi210697r9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease.","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"zoi210697r10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/apt.15830","article-title":"Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices.","volume":"52","author":"Younossi","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"zoi210697r11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.14309\/ajg.0000000000001054","article-title":"Role of noninvasive tests in clinical gastroenterology practices to identify patients with nonalcoholic steatohepatitis at high risk of adverse outcomes: expert panel recommendations.","volume":"116","author":"Younossi","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"zoi210697r13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jhep.2020.03.036","article-title":"Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis.","volume":"73","author":"Vali","year":"2020","journal-title":"J Hepatol"},{"key":"zoi210697r14","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15482","article-title":"Systematic review: accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosis.","author":"Sharma","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"zoi210697r15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/2050640619865133","article-title":"Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.","volume":"7","author":"Staufer","year":"2019","journal-title":"United European Gastroenterol J"},{"issue":"5","key":"zoi210697r16","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/hep.v70.5","article-title":"Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the Stellar trials.","volume":"70","author":"Anstee","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"zoi210697r17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"zoi210697r18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/(ISSN)1527-3350","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"zoi210697r19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1373\/jalm.2018.027359","article-title":"Derivation and performance of standardized enhanced liver fibrosis (ELF) test thresholds for the detection and prognosis of liver fibrosis.","volume":"3","author":"Day","year":"2019","journal-title":"J Appl Lab Med"},{"key":"zoi210697r21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.06.048","article-title":"A global survey of physicians knowledge about non-alcoholic fatty liver disease.","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"zoi210697r22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/hep.v71.2","article-title":"Defining the minimum acceptable diagnostic accuracy of noninvasive fibrosis testing in cirrhosis: a decision analytic modeling study.","volume":"71","author":"Majumdar","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"zoi210697r23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes.","volume":"2","author":"Younossi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"zoi210697r24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3350\/cmh.2018.0090","article-title":"Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update.","volume":"25","author":"Kim","year":"2019","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"zoi210697r25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/cld.v13.1","article-title":"Surveillance and diagnosis of hepatocellular carcinoma.","volume":"13","author":"Lim","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"zoi210697r26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.04.042","article-title":"Surveillance of patients with cirrhosis remains suboptimal in the United States.","author":"Yeo","year":"2021","journal-title":"J Hepatol"},{"key":"zoi210697r20","author":"Younossi","year":"2019"},{"key":"zoi210697r12","unstructured":"Biomarker qualification letter of intent (LOI) content elements. US Food and Drug Administration. Accessed June 4, 2021. https:\/\/www.fda.gov\/media\/135355\/download"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784186\/younossi_2021_oi_210697_1631040663.4742.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T15:02:25Z","timestamp":1631804545000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.23923","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]}}}